R. Giustolisi, “Combined intravitreal ranibizumab and verteporfin photodynamic therapy versus ranibizumab alone for the treatment of age-related macular degeneration”, Digit J Ophthalmol, vol. 17, no. 3, pp. 23–30, Sep. 2011.